Literature DB >> 9843804

Stimulation of cerebellar fastigial nucleus inhibits interleukin-1beta-induced cerebrovascular inflammation.

E Galea1, S B Glickstein, D L Feinstein, E V Golanov, D J Reis.   

Abstract

Electrical stimulation of the cerebellar fastigial nucleus (FN) in rat protects the brain against ischemia. We studied whether FN could reduce the cerebrovascular inflammation as a mechanism of protection. FN or dentate nucleus (sham controls) was electrically stimulated for 1 h, and 72 h later rats were either injected with interleukin (IL)-1beta into the striata or processed to analyze inflammatory responses in isolated brain microvessels. In striata, IL-1beta induced a recruitment of leukocytes that was reduced by 50% by FN stimulation. In isolated microvessels, IL-1beta induced the transient and dose-dependent upregulation of the mRNAs encoding for the inducible nitric oxide synthase (NOS-2), intercellular adhesion molecule 1 (ICAM-1), and inhibitory kappaB-alpha (IkappaB-alpha), an inhibitor of nuclear factor-kappaB. FN stimulation decreased the upregulation of NOS-2 and ICAM-1 mRNAs, whereas it increased IkappaB-alpha mRNA expression. Dentate nucleus stimulation did not mimic the FN actions. These findings suggest that FN stimulation may render brain microvessels refractory to IL-1beta by overproduction of IkappaB-alpha and support the hypothesis that alteration of microvascular inflammation may contribute to the central neurogenic neuroprotection elicited from the FN.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9843804     DOI: 10.1152/ajpheart.1998.275.6.H2053

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  12 in total

Review 1.  Mechanisms of the Anti-Ischemic Effect of Angiotensin II AT( 1 ) Receptor Antagonists in the Brain.

Authors:  Juan M Saavedra; Julius Benicky; Jin Zhou
Journal:  Cell Mol Neurobiol       Date:  2006-04-25       Impact factor: 5.046

Review 2.  Neurogenic neuroprotection.

Authors:  Eugene V Golanov; Ping Zhou
Journal:  Cell Mol Neurobiol       Date:  2003-10       Impact factor: 5.046

3.  Central Nervous System Electrical Stimulation for Neuroprotection in Acute Cerebral Ischemia: Meta-Analysis of Preclinical Studies.

Authors:  Mersedeh Bahr Hosseini; Jesse Hou; Marom Bikson; Marco Iacoboni; Jeffrey Gornbein; Jeffrey L Saver
Journal:  Stroke       Date:  2019-09-04       Impact factor: 7.914

4.  Amount but not pattern of protective sensory stimulation alters recovery after permanent middle cerebral artery occlusion.

Authors:  Melissa F Davis; Christopher C Lay; Cynthia H Chen-Bee; Ron D Frostig
Journal:  Stroke       Date:  2011-02-11       Impact factor: 7.914

5.  Intrinsic neurons of fastigial nucleus mediate neurogenic neuroprotection against excitotoxic and ischemic neuronal injury in rat.

Authors:  S B Glickstein; E V Golanov; D J Reis
Journal:  J Neurosci       Date:  1999-05-15       Impact factor: 6.167

6.  Fastigial nucleus electrostimulation reduces the expression of repulsive guidance molecule, improves axonal growth following focal cerebral ischemia.

Authors:  Fan Jiang; Honglei Yin; Xinyue Qin
Journal:  Neurochem Res       Date:  2012-06-13       Impact factor: 3.996

Review 7.  Intrinsic regulation of brain inflammatory responses.

Authors:  Elena Galea; Michael T Heneka; Cinzia Dello Russo; Douglas L Feinstein
Journal:  Cell Mol Neurobiol       Date:  2003-10       Impact factor: 5.046

8.  Neurogenic neuroprotection: clinical perspectives.

Authors:  Mauricio Mandel; Erich Talamoni Fonoff; Edson Bor-Seng-Shu; Manoel Jacobsen Teixeira; Gerson Chadi
Journal:  Funct Neurol       Date:  2012 Oct-Dec

9.  Regional genome transcriptional response of adult mouse brain to hypoxia.

Authors:  Huichun Xu; Aigang Lu; Frank R Sharp
Journal:  BMC Genomics       Date:  2011-10-11       Impact factor: 3.969

Review 10.  Immune mechanisms in cerebral ischemic tolerance.

Authors:  Lidia Garcia-Bonilla; Corinne Benakis; Jamie Moore; Costantino Iadecola; Josef Anrather
Journal:  Front Neurosci       Date:  2014-03-04       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.